Atherosclerosis Drugs Market Size Analysis, Industry Outlook, & Region Forecast till 2027 The report’s authors have offered necessary details on the latest Atherosclerosis Drugs market trends and the crucial parameters impacting both short-term and long-term market growth. Its panoramic view of the Atherosclerosis Drugs market entails useful insights into the estimated Atherosclerosis Drugs market size, revenue share, and sales & distribution networks. Such helpful market insights are bound to help readers outline this industry’s key outcomes in the near future. The global atherosclerosis drugs market size reached USD 48.40 Billion in 2021 and is expected to register a revenue CAGR of 2.5% during the forecast period, according to latest analysis by Emergen Research. An increase in the prevalence of atherosclerosis & cardiovascular diseases is the main factor driving the revenue growth of the atherosclerosis drugs market. Globally, the number of cardiovascular disease-related deaths and disabilities has been continuously increasing over the past 30 years. The illness, which includes heart disease and stroke, was to blame for a startling one-third of all fatalities globally in 2019. In the United States alone, heart disease is the leading cause of death for both sexes and members of the majority of racial and ethnic groups. Cardiovascular disease claims one life in the United States every 34 seconds. In the United States, heart disease claimed the lives of almost 697,000 individuals in 2020, accounting for 1 in 5 fatalities. Between 2017 and 2018, heart disease cost the USD 229 billion annually. This covers the price of prescription drugs, healthcare services, and lost income from deaths. Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1300